Contract services with data analysis included. All domestic options available for peace of mind. RNA-seq is currently on a campaign for 60,000 yen for the usual 9Gb or a limited 6Gb for this fiscal year.
Our NGS contract services come with data analysis included, ensuring peace of mind even for first-time users. For expression analysis, simply send Total RNA for "RNA-seq" or "CAGE," and we will deliver the analysis data via USB or HDD. We also offer rRNA removal and de novo assembly tailored to your needs. "CAGE" allows for more quantitative gene expression analysis compared to "RNA-seq." "NET-CAGE" is a new technology for enhancer RNA analysis. Other services include "ATAC-seq," "ChIP-seq," "WES," "WGS," and more. The MGI DNBSEQ sequencer has been fully operational since autumn 2021, with an expansion in autumn 2022 and the introduction of the Illumina NextSeq 2000. 【Features】 ■ The submitted RNA for RNA-seq is total RNA 1ug ■ For RNA-seq, starting with 10ng is possible for human and mouse samples ■ Analysis of a single cell is available, and Ultra Low RNA-seq is a popular plan ■ RNA extraction option ■ We also provide unnecessary RNA removal and de novo assembly tailored to your objectives *Please feel free to contact us for arrangements regarding analysis conditions.
Inquire About This Product
basic information
【Other Analysis Contract Services】 ■ Human Whole Exome - Covers approximately 20,000 genes. Efficiently identifies mutations in disease-related genes at low cost. ■ Human Cancer Panel (QIAseq panel) - Highly sensitive detection of somatic mutations in target genes from FFPE samples. ■ ATAC-seq - Comprehensive analysis of open chromatin regions. Library preparation available as a service. ■ ChIP-seq - Comprehensive analysis of histone modifications and transcription factor binding sites. * Please feel free to contact us.
Price range
P2
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us or refer to the PDF materials.
catalog（6）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.